Literature DB >> 16141001

Genetic and clinical aspects of Zellweger spectrum patients with PEX1 mutations.

H Rosewich1, A Ohlenbusch, J Gärtner.   

Abstract

OBJECTIVE: To analyse the PEX1 gene, the most common cause for peroxisome biogenesis disorders (PBD), in a consecutive series of patients with Zellweger spectrum.
METHODS: Mutations were detected by different methods including SSCP analyses as a screening technique on the basis of genomic or cDNA, followed by direct sequencing of PCR fragments with an abnormal electrophoresis pattern.
RESULTS: 33 patients were studied. Two common mutations, c.2528G-->A, G843D and c.2098_2098insT, I700YfsX42, accounted for over 80% of all abnormal PEX1 alleles, emphasising their diagnostic relevance. Most PEX1 mutations were distributed over the two AAA cassettes with the two functional protein domains, D1 and D2, and the highly conserved Walker motifs. Phenotypic severity of Zellweger spectrum in CG1 depended on the effect of the mutation on the PEX1 protein, peroxin 1. PEX1 mutations could be divided into two classes of genotype-phenotype correlation: class I mutations led to residual PEX1 protein levels and function and a milder phenotype; class II mutations almost abolished PEX1 protein levels and function, resulting in a severe phenotype. Compound heterozygote patients for a class I and class II mutation had an intermediate phenotype.
CONCLUSIONS: Molecular confirmation of the clinical and biochemical diagnosis will allow the prediction of the clinical course of disease in individual PBD cases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16141001      PMCID: PMC1736134          DOI: 10.1136/jmg.2005.033324

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  17 in total

Review 1.  Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelines.

Authors:  Nancy E Braverman; Gerald V Raymond; William B Rizzo; Ann B Moser; Mark E Wilkinson; Edwin M Stone; Steven J Steinberg; Michael F Wangler; Eric T Rush; Joseph G Hacia; Mousumi Bose
Journal:  Mol Genet Metab       Date:  2015-12-23       Impact factor: 4.797

2.  Lymphoblastoid cell lines for diagnosis of peroxisome biogenesis disorders.

Authors:  Sabine Grønborg; Ralph Krätzner; Hendrik Rosewich; Jutta Gärtner
Journal:  JIMD Rep       Date:  2011-06-22

3.  Clinical utility gene card for: Zellweger syndrome spectrum.

Authors:  Hendrik Rosewich; Hans Waterham; Bwee Tien Poll-The; Andreas Ohlenbusch; Jutta Gärtner
Journal:  Eur J Hum Genet       Date:  2014-11-19       Impact factor: 4.246

4.  Diagnostic and prognostic value of in vivo proton MR spectroscopy for Zellweger syndrome spectrum patients.

Authors:  H Rosewich; P Dechent; C Krause; A Ohlenbusch; K Brockmann; J Gärtner
Journal:  J Inherit Metab Dis       Date:  2016-08-03       Impact factor: 4.982

Review 5.  Characterization of Severity in Zellweger Spectrum Disorder by Clinical Findings: A Scoping Review, Meta-Analysis and Medical Chart Review.

Authors:  Mousumi Bose; Christine Yergeau; Yasmin D'Souza; David D Cuthbertson; Melisa J Lopez; Alyssa K Smolen; Nancy E Braverman
Journal:  Cells       Date:  2022-06-10       Impact factor: 7.666

6.  Rational diagnostic strategy for Zellweger syndrome spectrum patients.

Authors:  Cindy Krause; Hendrik Rosewich; Jutta Gärtner
Journal:  Eur J Hum Genet       Date:  2009-01-14       Impact factor: 4.246

7.  Zellweger syndrome with severe malnutrition, immunocompromised state and opportunistic infections.

Authors:  Patrícia Cardoso; Maria Emanuel Amaral; Sónia Lemos; Paula Garcia
Journal:  BMJ Case Rep       Date:  2016-04-18

8.  Identification of novel mutations and sequence variation in the Zellweger syndrome spectrum of peroxisome biogenesis disorders.

Authors:  Wing Yan Yik; Steven J Steinberg; Ann B Moser; Hugo W Moser; Joseph G Hacia
Journal:  Hum Mutat       Date:  2009-03       Impact factor: 4.878

9.  Characterization of two common 5' polymorphisms in PEX1 and correlation to survival in PEX1 peroxisome biogenesis disorder patients.

Authors:  Sven Thoms; Sabine Grønborg; Jana Rabenau; Andreas Ohlenbusch; Hendrik Rosewich; Jutta Gärtner
Journal:  BMC Med Genet       Date:  2011-08-16       Impact factor: 2.103

10.  The peroxisomal disorder spectrum and Heimler syndrome: Deep phenotyping and review of the literature.

Authors:  Malena Daich Varela; Priyam Jani; Wadih M Zein; Precilla D'Souza; Lynne Wolfe; Jennifer Chisholm; Christopher Zalewski; David Adams; Blake M Warner; Laryssa A Huryn; Robert B Hufnagel
Journal:  Am J Med Genet C Semin Med Genet       Date:  2020-08-31       Impact factor: 3.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.